Pasithea Therapeutics Corp (KTTA)
6.92
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
7.05
+0.13
(+1.88%)
After-Hours: 20:00
Pasithea Therapeutics Market Cap: 7.213M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 7.213M |
| May 02, 2024 | 7.213M |
| May 01, 2024 | 7.213M |
| April 30, 2024 | 7.213M |
| April 29, 2024 | 7.213M |
| April 26, 2024 | 7.547M |
| April 25, 2024 | 7.547M |
| April 24, 2024 | 7.245M |
| April 23, 2024 | 7.391M |
| April 22, 2024 | 7.047M |
| April 19, 2024 | 7.412M |
| April 18, 2024 | 7.453M |
| April 17, 2024 | 7.453M |
| April 16, 2024 | 7.557M |
| April 15, 2024 | 7.453M |
| April 12, 2024 | 7.776M |
| April 11, 2024 | 7.974M |
| April 10, 2024 | 8.548M |
| April 09, 2024 | 8.595M |
| April 08, 2024 | 8.808M |
| April 05, 2024 | 8.860M |
| April 04, 2024 | 9.121M |
| April 03, 2024 | 8.329M |
| April 02, 2024 | 7.536M |
| April 01, 2024 | 7.558M |
| Date | Value |
|---|---|
| March 28, 2024 | 7.558M |
| March 27, 2024 | 7.453M |
| March 26, 2024 | 7.609M |
| March 25, 2024 | 7.433M |
| March 22, 2024 | 6.982M |
| March 21, 2024 | 7.471M |
| March 20, 2024 | 7.084M |
| March 19, 2024 | 7.105M |
| March 18, 2024 | 7.412M |
| March 15, 2024 | 7.265M |
| March 14, 2024 | 7.501M |
| March 13, 2024 | 7.579M |
| March 12, 2024 | 7.527M |
| March 11, 2024 | 7.814M |
| March 08, 2024 | 7.594M |
| March 07, 2024 | 7.501M |
| March 06, 2024 | 7.546M |
| March 05, 2024 | 7.438M |
| March 04, 2024 | 7.991M |
| March 01, 2024 | 8.470M |
| February 29, 2024 | 8.334M |
| February 28, 2024 | 7.918M |
| February 27, 2024 | 7.605M |
| February 26, 2024 | 7.709M |
| February 23, 2024 | 7.730M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.834M
Minimum
Dec 20 2023
93.02M
Maximum
Nov 29 2021
20.94M
Average
18.15M
Median
Jan 27 2023
Market Cap Benchmarks
| CEL-SCI Corp | 87.99M |
| AIM ImmunoTech Inc | 20.20M |
| IGC Pharma Inc | 32.58M |
| NovaBay Pharmaceuticals Inc | 2.856M |
| Protalix BioTherapeutics Inc | 83.28M |
Market Cap Related Metrics
| Price to Book Value | 0.3083 |
| Price | 6.92 |
| Earnings Yield | -188.0% |